Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Phase II Study of Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations
Brief Summary: The purpose of this research study is to look at participants with solid tumor malignancies and specific mutations respond to treatment with everolimus.